# Everolimus in Treating Patients WIth Recurrent or Metastatic Breast Cancer

> **NCT00255788** · PHASE2 · COMPLETED · sponsor: **NCIC Clinical Trials Group** · enrollment: 49 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** everolimus

## Key facts

- **NCT ID:** NCT00255788
- **Lead sponsor:** NCIC Clinical Trials Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05-10
- **Primary completion:** 2008-07-22
- **Final completion:** 2011-01-18
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2023-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00255788

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00255788, "Everolimus in Treating Patients WIth Recurrent or Metastatic Breast Cancer". Retrieved via AI Analytics 2026-09-09 from https://api.ai-analytics.org/clinical/NCT00255788. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*